The affected products are from the brands Losartas, Losagen and Hyperten
31 Mar 2019
Three brands of high blood pressure medicine containing the ingredient losartan have been recalled because they contain higher than acceptable levels of a potentially harmful impurity, the Health Sciences Authority (HSA) said on Thursday (Mar 28).
The drugs contain the active ingredient losartan potassium, which was manufactured by Indian pharmaceutical company Hetero Labs.
The affected products are the 50mg and 100mg tablets from the brands Losartas, Losagen and Hyperten and distributed by local suppliers Apotheca Marketing, Medicell Pharmaceutical and Goldplus Universal, respectively.
About 137,000 patients in Singapore are using the three recalled brands of losartan medicine, said the Ministry of Health (MOH).
Losartas is prescribed in public healthcare institutions, while Losartas, Losagen and Hyperten are prescribed at private healthcare institutions.
HSA has advised patients not to stop treatment on their own as there is no immediate health risk and sudden stopping of the drugs can pose greater immediate risk to their health.
